These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 23021437)
1. Parameningeal rhabdomyosarcoma: outcomes and opportunities. Yang JC; Wexler LH; Meyers PA; Wolden SL Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e61-6. PubMed ID: 23021437 [TBL] [Abstract][Full Text] [Related]
2. Delayed radiotherapy following dose intensive chemotherapy for parameningeal rhabdomyosarcoma (PM-RMS) of childhood. Douglas JG; Arndt CA; Hawkins DS Eur J Cancer; 2007 Apr; 43(6):1045-50. PubMed ID: 17368885 [TBL] [Abstract][Full Text] [Related]
3. Patterns of failure for rhabdomyosarcoma of the perineal and perianal region. Casey DL; Wexler LH; LaQuaglia MP; Meyers PA; Wolden SL Int J Radiat Oncol Biol Phys; 2014 May; 89(1):82-7. PubMed ID: 24725692 [TBL] [Abstract][Full Text] [Related]
4. Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas. Chen C; Shu HK; Goldwein JW; Womer RB; Maity A Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1294-9. PubMed ID: 12654440 [TBL] [Abstract][Full Text] [Related]
5. The challenging role of radiation therapy for very young children with rhabdomyosarcoma. Puri DR; Wexler LH; Meyers PA; La Quaglia MP; Healey JH; Wolden SL Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1177-84. PubMed ID: 16682130 [TBL] [Abstract][Full Text] [Related]
6. Worse Outcomes for Head and Neck Rhabdomyosarcoma Secondary to Reduced-Dose Cyclophosphamide. Casey DL; Wexler LH; Wolden SL Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1151-1157. PubMed ID: 30508617 [TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience. Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834 [TBL] [Abstract][Full Text] [Related]
8. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV. Michalski JM; Meza J; Breneman JC; Wolden SL; Laurie F; Jodoin M; Raney B; Wharam MD; Donaldson SS Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1027-38. PubMed ID: 15234036 [TBL] [Abstract][Full Text] [Related]
9. Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma. Wolden SL; La TH; LaQuaglia MP; Meyers PA; Kraus DH; Wexler LH Cancer; 2003 Jan; 97(1):179-85. PubMed ID: 12491519 [TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated radiotherapy with use of cone-down boost for pediatric head-and-neck rhabdomyosarcoma. McDonald MW; Esiashvili N; George BA; Katzenstein HM; Olson TA; Rapkin LB; Marcus RB Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):884-91. PubMed ID: 18455321 [TBL] [Abstract][Full Text] [Related]
11. Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Curtis AE; Okcu MF; Chintagumpala M; Teh BS; Paulino AC Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):173-7. PubMed ID: 18501529 [TBL] [Abstract][Full Text] [Related]
12. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma. Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):718-725. PubMed ID: 33516439 [TBL] [Abstract][Full Text] [Related]
14. Intensity modulated radiation therapy with dose painting to treat rhabdomyosarcoma. Yang JC; Dharmarajan KV; Wexler LH; La Quaglia MP; Happersett L; Wolden SL Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e371-7. PubMed ID: 22658517 [TBL] [Abstract][Full Text] [Related]
15. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy. Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of patients with head-and-neck cancer of unknown primary origin treated with intensity-modulated radiotherapy. Shoushtari A; Saylor D; Kerr KL; Sheng K; Thomas C; Jameson M; Reibel J; Shonka D; Levine P; Read P Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e83-91. PubMed ID: 21377283 [TBL] [Abstract][Full Text] [Related]
17. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases]. Yu L; Wang J Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377 [TBL] [Abstract][Full Text] [Related]
18. Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group. Wolden SL; Lyden ER; Arndt CA; Hawkins DS; Anderson JR; Rodeberg DA; Morris CD; Donaldson SS Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1071-6. PubMed ID: 26581144 [TBL] [Abstract][Full Text] [Related]
20. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study. Wharam MD; Meza J; Anderson J; Breneman JC; Donaldson SS; Fitzgerald TJ; Michalski J; Teot LA; Wiener ES; Meyer WH J Clin Oncol; 2004 May; 22(10):1902-8. PubMed ID: 15143083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]